- Report
- April 2026
- 146 Pages
Global
From €2724EUR$2,999USD£2,323GBP
€3633EUR$3,999USD£3,098GBP
- Report
- April 2026
- 136 Pages
Global
From €2724EUR$2,999USD£2,323GBP
€3633EUR$3,999USD£3,098GBP
- Report
- April 2026
- 146 Pages
Global
From €2724EUR$2,999USD£2,323GBP
€3633EUR$3,999USD£3,098GBP
- Report
- April 2026
- 147 Pages
Global
From €2724EUR$2,999USD£2,323GBP
€3633EUR$3,999USD£3,098GBP
- Report
- April 2026
- 136 Pages
Global
From €2724EUR$2,999USD£2,323GBP
€3633EUR$3,999USD£3,098GBP
- Report
- April 2026
- 141 Pages
Global
From €2724EUR$2,999USD£2,323GBP
€3633EUR$3,999USD£3,098GBP
- Report
- April 2026
- 150 Pages
Global
From €2724EUR$2,999USD£2,323GBP
€3633EUR$3,999USD£3,098GBP
- Report
- March 2026
- 145 Pages
Global
From €2724EUR$2,999USD£2,323GBP
€3633EUR$3,999USD£3,098GBP
- Report
- May 2026
- 304 Pages
Global
From €2271EUR$2,500USD£1,937GBP
- Report
- May 2026
- 333 Pages
Global
From €2271EUR$2,500USD£1,937GBP
- Report
- April 2026
- 286 Pages
Global
From €2271EUR$2,500USD£1,937GBP
- Report
- January 2026
- 291 Pages
Global
From €2271EUR$2,500USD£1,937GBP
- Report
- January 2026
- 280 Pages
Global
From €2271EUR$2,500USD£1,937GBP
- Report
- August 2025
- 220 Pages
Global
From €2271EUR$2,500USD£1,937GBP
- Report
- June 2026
- 150 Pages
Global
From €4315EUR$4,750USD£3,679GBP
- Report
- May 2026
- 140 Pages
Global
From €4315EUR$4,750USD£3,679GBP
- Report
- May 2026
- 110 Pages
Global
From €4315EUR$4,750USD£3,679GBP
- Report
- May 2026
- 180 Pages
Global
From €4315EUR$4,750USD£3,679GBP
- Report
- April 2026
- 180 Pages
Global
From €4315EUR$4,750USD£3,679GBP
- Report
- January 2026
- 120 Pages
Global
From €4315EUR$4,750USD£3,679GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more